Skip to main content
. 2006 Apr 18;62(2):218–224. doi: 10.1111/j.1365-2125.2006.02621.x

Table 2.

Prescription rates (95% CIs) of prescribing quality indicators applied to Eastern Regional Health Authority (ERHA) prescription database

Prescribing quality indicator Prescribing rate in database (95% CI)
A high ratio of prescribing of inhaled corticosteroid to inhaled bronchodilators in patients with moderate to severe asthma 1.57 : 1
A rate of prescribing statins and aspirin in patients with NIDDM (n = 8093)
 Aspirin 64.70% (63.66, 65.74)
 Statins 59. 14% (58.07, 60.21)
 Aspirin + statins 44.23% (43.15, 45.31)
A low rate of benzodiazepine prescribing for prolonged periods (>4 weeks) (n = 18 171) 52.48% (51.95, 53.01)
A high rate of generic prescribing (n = 158 128) 17.78% (17.70, 17.90)
A high rate of prescribing of paracetamol compared with NSAIDs in patients with concomitant heart failure (n = 1396). 1 : 1.49
 Paracetamol 8.24% (6.80, 9.68)
 Nonsteroidal anti-inflammatory drugs 12.25% (10.53, 13.97)
A low rate of coprescription of potassium supplements or potassium sparing diuretics for patients receiving ACE inhibitors or angiotensin antagonists (n = 37 074) 2.32% (2.17, 2.47)
 Potassium supplements (n = 196) 0.53% (0.46, 0.60)
 Potassium sparing diuretics (n = 679) 1.83% (1.69, 1.97)
A high rate of prescribing thromboembolic prophylaxis in patients over 75 years on digoxin (n = 4380) 75.78% (74.51, 77.05)
A low rate of prescribing broad spectrum antibiotics such as coamoxyclav items as percentage of total antibiotics (n = 16 742). 38.73% (38.27, 39.19)
 Quinolone items 5.84% (5.62, 6.06)
 Co-amoxyclav items 32.89% (32.45, 33.33)
A low rate of prescribing proton pump inhibitors at full curative dose for > 4 weeks rather than a maintenance dose (n = 21 935) 52.92% (52.44, 53.40)
A low rate of prescribing of oral nutritional supplements
 All ages (n = 182 175) 3.39% (3.31, 3.47)
 Over 65s (n = 90 869) 6.76% (6.60, 6.92)
A low rate of prescribing compound analgesics relative to paracetamol 1.56 : 1

NIDDM, Non-insulin-dependent diabetes mellitus; NSAID, nonsteroidal anti-inflammatory drug.